Macular degeneration, or Age-related macular degeneration (AMD or ARMD), is a common leading cause of vision loss in people 60 years or older.
Diabetic Retinopathy is a diabetes complication that affects the vision. It can be developed in anyone who has type 1 or Type 2 diabetes. The longer you have diabetes left untreated, the more likely you are to develop this eye complication.
Glaucoma is a group of eye conditions that damage the optic nerve that sends information from the eye to the brain. Glaucoma is often related to increased pressure in the eye, called intraocular pressure.
Dry eyes is a common condition when your tears aren’t able to provide adequate lubrication for your eyes. It is estimated that thirty percent of Canadians experience ocular symptoms associated with dry eyes.
Retinitis Pigmentosa (RP) is a hereditary disorder that causes progressive vision loss and may eventually lead to blindness. RP affects approximately 1 in 5000 individuals worldwide.
Optic neuritis is an inflammatory condition affecting the optic nerve, the pathway that carries visual information from the eye to the brain. When this nerve becomes inflamed, visual signals are disrupted, leading to sudden changes in vision. Symptoms can range from blurred or dim vision to faded colors or reduced night vision.
Central Serous Retinopathy (CSR) also known as Central Serous Chorioretinopathy is a condition where fluid builds up underneath the central retina (the macula). This happens when fluid leaks through a weakened layer beneath the retina, causing the macula to lift slightly. As a result, vision may suddenly become blurred, distorted, dim, or washed out. Select 46 more words to run Humanizer.
Strabismus, commonly known as crossed eyes, is a condition in which the eyes do not align properly. One or both eyes may turn inward, outward, upward, or downward instead of working together as a coordinated pair.
Retinitis Pigmentosa (RP) is a hereditary disorder that causes progressive vision loss and may eventually lead to blindness. RP affects approximately 1 in 5000 individuals worldwide.
